Citigroup Maintains Neutral Rating on Haemonetics, Lowers PT to $75.

Friday, Feb 6, 2026 2:03 pm ET1min read
C--
HAE--

Citigroup Maintains Neutral Rating on Haemonetics, Lowers PT to $75.

Citigroup Maintains Neutral Rating on Haemonetics, Lowers PT to $75.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet